X-linked sideroblastic anemia with ataxia

disease
On this page

Also known as anaemia sideroblastic and spinocerebellar ataxiaanemia, Sex-linked hypochromic Sideroblaanemia, sideroblastic, and spinocerebellar ataxiaanemia, sideroblastic, with ataxia, X-linked recessiveASATPagon Bird Detter syndromePagon-Bird-Detter syndromesideroblastic anaemia with spinocerebellar ataxiasideroblastic anemia with spinocerebellar ataxiaX-linked sideroblastic Anaemia and ataxiaX-linked sideroblastic anaemia and spinocerebellar ataxiaX-linked sideroblastic anaemia with spinocerebellar ataxiaX-linked sideroblastic Anemia and ataxiaX-linked sideroblastic anemia with spinocerebellar ataxiaXLSA-A

Summary

X-linked sideroblastic anemia with ataxia (MONDO:0010524) is a disease caused by ABCB7 (GenCC Definitive), with 1 cohort gene.

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Causal gene: ABCB7 (GenCC Definitive)
  • Cohort genes: 1
  • ClinVar variants: 29
  • Phenotypes (HPO): 32

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families13WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Signs & symptoms

Clinical features (HPO)

32 HPO clinical features (Orphanet curated; top 32 by frequency):

HPO IDTermFrequency
HP:0001251AtaxiaVery frequent (80-99%)
HP:0001903AnemiaVery frequent (80-99%)
HP:0002066Gait ataxiaVery frequent (80-99%)
HP:0002167Abnormality of speech or vocalizationVery frequent (80-99%)
HP:0012187Increased erythrocyte protoporphyrin concentrationVery frequent (80-99%)
HP:0031936Delayed ability to walkVery frequent (80-99%)
HP:0000486StrabismusFrequent (30-79%)
HP:0000639NystagmusFrequent (30-79%)
HP:0000750Delayed speech and language developmentFrequent (30-79%)
HP:0001260DysarthriaFrequent (30-79%)
HP:0001347HyperreflexiaFrequent (30-79%)
HP:0001348Brisk reflexesFrequent (30-79%)
HP:0001924Sideroblastic anemiaFrequent (30-79%)
HP:0002172Postural instabilityFrequent (30-79%)
HP:0002194Delayed gross motor developmentFrequent (30-79%)
HP:0004840Hypochromic microcytic anemiaFrequent (30-79%)
HP:0011273AnisocytosisFrequent (30-79%)
HP:0000717AutismOccasional (5-29%)
HP:0001252HypotoniaOccasional (5-29%)
HP:0001272Cerebellar atrophyOccasional (5-29%)
HP:0001310DysmetriaOccasional (5-29%)
HP:0001510Growth delayOccasional (5-29%)
HP:0002075DysdiadochokinesisOccasional (5-29%)
HP:0004447PoikilocytosisOccasional (5-29%)
HP:0020081Pappenheimer bodiesOccasional (5-29%)
HP:0034499Increased bone marrow ironOccasional (5-29%)
HP:0000028CryptorchidismVery rare (<1-4%)
HP:0000716DepressionVery rare (<1-4%)
HP:0001250SeizureVery rare (<1-4%)
HP:0001992Organic aciduriaVery rare (<1-4%)
HP:0100543Cognitive impairmentVery rare (<1-4%)
HP:0100753SchizophreniaVery rare (<1-4%)

Identifiers

Disease identifiers

FieldValue
Canonical nameX-linked sideroblastic anemia with ataxia
Mondo IDMONDO:0010524
MeSHC536358
OMIM301310
Orphanet2802
DOIDDOID:0050554, DOID:0060064
SNOMED CT719816006
UMLSC1845028
MedGen335078
GARD0000668
Is cancer (heuristic)no

Also known as: anaemia sideroblastic and spinocerebellar ataxia · anemia, Sex-linked hypochromic Siderobla · anemia, sideroblastic, and spinocerebellar ataxia · anemia, sideroblastic, with ataxia, X-linked recessive · ASAT · Pagon Bird Detter syndrome · Pagon-Bird-Detter syndrome · sideroblastic anaemia with spinocerebellar ataxia · sideroblastic anemia with spinocerebellar ataxia · X-linked sideroblastic Anaemia and ataxia · X-linked sideroblastic anaemia and spinocerebellar ataxia · X-linked sideroblastic anaemia with spinocerebellar ataxia · X-linked sideroblastic Anemia and ataxia · X-linked sideroblastic anemia with ataxia · X-linked sideroblastic anemia with spinocerebellar ataxia · XLSA-A · Xlsa-A

Data availability: 29 ClinVar variants · 7 GenCC gene-disease records.

Disease family

Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary diseaseX-linked disease › X-linked cerebellar ataxia › X-linked sideroblastic anemia with ataxia

Related subtypes (8): ataxia - deafness - intellectual disability syndrome, fragile X-associated tremor/ataxia syndrome, X-linked non progressive cerebellar ataxia, X-linked spinocerebellar ataxia type 3, X-linked spinocerebellar ataxia type 4, X-linked progressive cerebellar ataxia, spinocerebellar ataxia, X-linked 2, X-linked intellectual disability-ataxia-apraxia syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

29 retrieved; paginated sample, class counts are floors:

11 uncertain significance, 5 benign, 4 pathogenic, 3 benign/likely benign, 3 likely pathogenic, 3 conflicting classifications of pathogenicity

ClinVarVariant (HGVS)GeneClassificationReview
11574NM_001271696.3(ABCB7):c.1200T>G (p.Ile400Met)ABCB7Pathogeniccriteria provided, single submitter
11575NM_001271696.3(ABCB7):c.1297G>A (p.Glu433Lys)ABCB7Pathogenicno assertion criteria provided
11576NM_001271696.3(ABCB7):c.1231G>C (p.Val411Leu)ABCB7Pathogenicno assertion criteria provided
126455NM_001271696.3(ABCB7):c.624A>T (p.Glu208Asp)ABCB7Pathogenicno assertion criteria provided
3235083NM_001271696.3(ABCB7):c.1231G>T (p.Val411Leu)ABCB7Likely pathogeniccriteria provided, single submitter
3248639NM_001271696.3(ABCB7):c.2021A>G (p.Asp674Gly)ABCB7Likely pathogeniccriteria provided, single submitter
372878NM_001271696.3(ABCB7):c.1235T>C (p.Met412Thr)ABCB7Likely pathogeniccriteria provided, single submitter
368656NM_001271696.3(ABCB7):c.1492G>A (p.Gly498Arg)ABCB7Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
368659NM_001271696.3(ABCB7):c.168+13T>CABCB7Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
914076NM_001271696.3(ABCB7):c.1802A>G (p.Gln601Arg)ABCB7Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
1333913NM_001271696.3(ABCB7):c.2066C>T (p.Thr689Ile)ABCB7Uncertain significancecriteria provided, single submitter
2438737NM_001271696.3(ABCB7):c.1106A>G (p.Lys369Arg)ABCB7Uncertain significancecriteria provided, single submitter
2582478NM_001271696.3(ABCB7):c.358A>G (p.Ile120Val)ABCB7Uncertain significancecriteria provided, single submitter
368655NM_001271696.3(ABCB7):c.1935+5G>CABCB7Uncertain significancecriteria provided, multiple submitters, no conflicts
4077766NM_001271696.3(ABCB7):c.2020G>A (p.Asp674Asn)ABCB7Uncertain significancecriteria provided, single submitter
814010NM_001271696.3(ABCB7):c.1936-3C>GABCB7Uncertain significancecriteria provided, single submitter
914074NM_001271696.3(ABCB7):c.*113A>GABCB7Uncertain significancecriteria provided, single submitter
914075NM_001271696.3(ABCB7):c.2073T>C (p.His691=)ABCB7Uncertain significancecriteria provided, single submitter
914587NM_001271696.3(ABCB7):c.1230A>G (p.Leu410=)ABCB7Uncertain significancecriteria provided, single submitter
914588NM_001271696.3(ABCB7):c.1200T>C (p.Ile400=)ABCB7Uncertain significancecriteria provided, single submitter
976048NM_001271696.3(ABCB7):c.944+3A>GABCB7Uncertain significancecriteria provided, single submitter
1188878NM_001271696.3(ABCB7):c.168+69C>GABCB7Benigncriteria provided, multiple submitters, no conflicts
136242NM_001271696.3(ABCB7):c.312C>T (p.Leu104=)ABCB7Benign/Likely benigncriteria provided, multiple submitters, no conflicts
136243NM_001271696.3(ABCB7):c.938G>A (p.Arg313Gln)ABCB7Benign/Likely benigncriteria provided, multiple submitters, no conflicts
136244NM_001271696.3(ABCB7):c.945-7C>TABCB7Benigncriteria provided, multiple submitters, no conflicts
136245NM_001271696.3(ABCB7):c.1739C>T (p.Ala580Val)ABCB7Benigncriteria provided, multiple submitters, no conflicts
368658NM_001271696.3(ABCB7):c.1032+12A>GABCB7Benign/Likely benigncriteria provided, multiple submitters, no conflicts
559334NM_001271696.3(ABCB7):c.201G>C (p.Gln67His)ABCB7Benigncriteria provided, multiple submitters, no conflicts
913727NM_001271696.3(ABCB7):c.211A>G (p.Lys71Glu)ABCB7Benigncriteria provided, single submitter

Genes & proteins

Mendelian disease overlap and somatic drivers

GenCC: 7 · Orphanet: 1 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0

GenCC gene–disease validity (cohort genes)

the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.

GeneClassificationInheritanceDiseaseRecords
ABCB7DefinitiveX-linkedX-linked sideroblastic anemia with ataxia7

Orphanet rare-disease linkage (cohort genes)

GeneOrphanet IDRare disease
ABCB7Orphanet:2802X-linked sideroblastic anemia and spinocerebellar ataxia

Cohort genes → proteins

1 cohort genes, 1 distinct canonical proteins.

Evidence partition

SubsetGenes
multi_evidence1

Cohort genes (full)

SymbolHGNCEnsemblUniProtNameEvidence
ABCB7HGNC:48ENSG00000131269O75027Iron-sulfur clusters transporter ABCB7, mitochondrialgencc,clinvar

Cohort function summary

Lead sentence per gene, UniProt-curated.

SymbolProtein nameFunction (lead sentence)
ABCB7Iron-sulfur clusters transporter ABCB7, mitochondrialExports glutathione-coordinated iron-sulfur clusters such as [2Fe-2S]-(GS)4 cluster from the mitochondria to the cytosol in an ATP-dependent manner allowing the assembly of the cytosolic iron-sulfur (Fe/S) cluster-containing proteins and p…

Protein-family classification

Druggable: 1 · Difficult: 0 · Unknown: 0 · Druggable fraction: 1.0

Family distribution

Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.

FamilyGenesFoldFDR
Transporter177.8×0.013

Per-gene assignment

SymbolFamilyDruggable?ECInterPro (top 3)
ABCB7TransporteryesABC_transporter-like_ATP-bd, AAA+_ATPase, ABC1_TM_dom

Expression context

Cohort genes with no expression data: 0.

1 cohort gene are a single-cell marker in ≥1 SCXA experiment.

Breadth distribution (Bgee present_calls)

BucketGenes
narrow (1-5 tissues)0
moderate (6-20)0
broad (>20)1
unknown0

Top tissues across cohort

TissueCohort genes
biceps brachii1
gluteal muscle1
triceps brachii1

Per-gene tissue summary (top 30)

SymbolBgee breadthFANTOM5 breadthSCXATop tissues
ABCB7273ubiquitousmarkerbiceps brachii, gluteal muscle, triceps brachii

Protein interactions among cohort

Intra-cohort edges: 0.

Hub genes (top 10 by interactor count)

SymbolInteractor count
ABCB71,838

Structural data

PDB: 1 · AlphaFold-only: 0 · No structure: 0

Cohort genes with PDB structures (top 30)

SymbolUniProtPDB entries
ABCB7O750274

Function

Pathway analysis

Distinct Reactome pathways touched by cohort: 5. Enrichment computed across 1 evidence-associated genes (1 with Reactome annotation).

Pathways by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

PathwayCohort genesFoldFDRSample cohort genes
Mitochondrial ABC transporters12855.0×0.002ABCB7
Cytosolic iron-sulfur cluster assembly1761.3×0.003ABCB7
ABC-family protein mediated transport1121.5×0.014ABCB7
Transport of small molecules125.1×0.050ABCB7
Metabolism111.6×0.086ABCB7

GO biological processes by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

GO termCohort genesFoldFDRSample cohort genes
iron-sulfur cluster export from the mitochondrion116852.0×2e-04ABCB7
positive regulation of iron-sulfur cluster assembly116852.0×2e-04ABCB7
positive regulation of heme biosynthetic process15617.3×5e-04ABCB7
iron ion transmembrane transport12407.4×8e-04ABCB7
negative regulation of reactive oxygen species biosynthetic process1991.3×0.002ABCB7
iron-sulfur cluster assembly1601.9×0.002ABCB7
intracellular iron ion homeostasis1244.2×0.005ABCB7
transmembrane transport1168.5×0.006ABCB7

Therapeutics

Drug target analysis

Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 1

Druggability breadth: 1 of 1 evidence-associated genes (100%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).

Top cohort targets by molecule count

SymbolMoleculesMax phase
ABCB700

Bioactivity and enzyme data

Enzyme cohort genes (≥1 EC): 0.

Cohort genes with ChEMBL bioactivity (full, sorted by assay count)

SymbolAssaysType breakdown
ABCB71Binding:1

Pharmacogenomics

Cohort genes with a PharmGKB record: 1; with CPIC/DPWG dosing guidelines: 0.

No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).

Chemical tractability of cohort targets

0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.

Druggability pyramid

Cohort genes binned by druggability tier (high → low):

TierDefinitionGenesSymbols
AApproved (phase 4 drug)0
BPhased (≥1) drug, not yet approved0
CDruggable family + PDB, no drug1ABCB7
DDruggable family + AlphaFold only, no drug0
EDifficult family or no structure, no drug0

Undrugged target profiles

1 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).

SymbolChEMBL assaysDrugged partners (top 3)
ABCB71

Clinical trials & evidence

Clinical trials

Clinical trials: 0.